SCHEMBL9764622

SCHEMBL9764622

CS(=O)(=O)Nc1ccc(/C=C\COCCCCCCNCc2ccccc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 2/20 0.47
DRD3 P35462 2/20 0.47
DRD4 P21917 1/20 0.47
MAOA P21397 1/20 0.42
NPC1 O15118 1/20 0.41
AR P10275 1/20 0.41
HPGD P15428 1/20 0.41
RAB9A P51151 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
CHRM2 P08172 1/20 0.41
ADRB2 P07550 1/20 0.41
ADRB1 P08588 1/20 0.41
ADRB3 P13945 1/20 0.41
ALOX5 P09917 1/20 0.40
HDAC3 O15379 2/20 0.39
HDAC1 Q13547 2/20 0.39
HDAC2 Q92769 2/20 0.39
HDAC8 Q9BY41 2/20 0.39
HDAC4 P56524 1/20 0.39
HDAC7 Q8WUI4 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9764632 1.00 DRD2 (0.47) DRD2DRD3DRD4MAOANPC1
SCHEMBL9763725 0.81 DRD2 (0.51) DRD2DRD3DRD4MAOANPC1
SCHEMBL9763382 0.80 NPC1 (0.43) NPC1HPGDRAB9ASMN1; SMN2ALOX5
SCHEMBL9762521 0.80 NPC1 (0.43) NPC1ARHPGDRAB9ASMN1; SMN2
SCHEMBL9762517 0.80 NPC1 (0.43) NPC1ARHPGDRAB9ASMN1; SMN2
SCHEMBL9763377 0.80 NPC1 (0.43) NPC1HPGDRAB9ASMN1; SMN2ALOX5
SCHEMBL9763494 0.77 DRD2 (0.47) DRD2DRD3DRD4MAOANPC1
SCHEMBL10478066 0.76 ADRB2 (0.49) SMN1; SMN2ADRB2ADRB1ADRB3
SCHEMBL10478060 0.76 ADRB2 (0.49) SMN1; SMN2ADRB2ADRB1ADRB3
SCHEMBL7907015 0.75 SIGMAR1 (0.64) DRD2DRD3DRD4MAOANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5006556-A Dichloroaniline derivatives for the therapy or prophylaxysis of a disease associated with reversible airway obstruction GLAXO GROUP LIMITED (GB) 1991-04-09 US disclosed
US-4943591-A TREATMENT OF ASTHMA AND BRONCHITIS GLAXO GROUP LIMITED (GB) 1990-07-24 US disclosed